Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.

Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.

The potential for amniotic fluid stem cell (AFSC) treatment to inhibit the progression of fibrotic lung injury has not been described. We have previously demonstrated that AFSC can attenuate both acute and chronic-fibrotic kidney injury through modification of the cytokine environment. Fibrotic lung...

Full description

Bibliographic Details
Main Authors: Orquidea Garcia, Gianni Carraro, Gianluca Turcatel, Marisa Hall, Sargis Sedrakyan, Tyler Roche, Sue Buckley, Barbara Driscoll, Laura Perin, David Warburton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3742516?pdf=render

Similar Items

Similar Items